kennedy glp 1 CMS Administrator Dr. Oz: “Obesity is not an absence of GLP-1 drugs—we’re all clear on that. But as Secretary said, it is an arrow in our quiver that we must use and should use…this is as MAHA Role of GLP-1A Receptor Agonists

NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi

Amycretins unique position: Its the only molecule in late-stage development that offers both a competitive subcutaneous formulation AND a potentially game-changing oral formulation

This study provides insight into how differential dynamics of peptideligand engagement with the GLP-1R TMD can promote differences in G protein-mediated signalling, improving molecular understanding of mechanisms that contribute to ligand-dependent differential efficacy at the GLP-1R

Caplan at Vitality MD, and Im regaining my old self again

In response to these environmental pressures, scientists must adapt by using any available resources as tools for discovery